Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
2021 · JAMA Neurology · 566 citations
https://doi.org/10.1001/jamaneurol.2021.3671
A
Agathe Vrillon
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
87
Papers
1.8K
Citations
20
h-index
29
i10-index
Agathe Vrillon is an academic researcher from Inserm. The author has contributed to research in topics: Alzheimer's disease research and treatments & Dementia and Cognitive Impairment Research & Parkinson's Disease Mechanisms and Treatments. The author has an h-index of 20, co-authored 74 publications.
ORCID: 0000-0002-0761-7885Papers by this author
worksMass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies
2023 · Nature Aging · 112 citations
https://doi.org/10.1038/s43587-023-00405-1
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
2021 · EMBO Molecular Medicine · 54 citations
https://doi.org/10.15252/emmm.202115098
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
2022 · Acta Neuropathologica · 54 citations
https://doi.org/10.1007/s00401-022-02469-6
Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease: a discovery cohort study
2022 · Alzheimer s Research & Therapy · 34 citations
https://doi.org/10.1186/s13195-022-01014-7
Using virtual reality in lumbar puncture training improves students learning experience
2022 · BMC Medical Education · 30 citations
https://doi.org/10.1186/s12909-022-03317-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat